Entera Bio Ltd. (ENTX)
2.92
-0.10
(-3.31%)
USD |
NASDAQ |
Oct 23, 16:00
2.905
-0.02
(-0.51%)
After-Hours: 20:00
Entera Bio Market Cap : 143.93M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 143.93M |
| October 22, 2026 | 148.86M |
| October 21, 2026 | 150.34M |
| October 20, 2026 | 148.86M |
| October 19, 2026 | 144.91M |
| October 16, 2026 | 132.10M |
| October 15, 2026 | 136.53M |
| October 14, 2026 | 123.23M |
| October 13, 2026 | 122.73M |
| October 12, 2026 | 130.62M |
| October 09, 2026 | 131.11M |
| October 08, 2026 | 123.23M |
| October 07, 2026 | 123.72M |
| October 06, 2026 | 124.70M |
| October 05, 2026 | 129.14M |
| October 02, 2026 | 140.97M |
| October 01, 2026 | 142.45M |
| September 30, 2026 | 143.43M |
| September 29, 2026 | 132.59M |
| September 28, 2026 | 132.59M |
| September 25, 2026 | 135.30M |
| September 24, 2026 | 138.01M |
| September 23, 2026 | 138.51M |
| September 22, 2026 | 146.88M |
| September 21, 2026 | 145.90M |
| Date | Value |
|---|---|
| September 18, 2026 | 145.90M |
| September 17, 2026 | 149.35M |
| September 16, 2026 | 145.90M |
| September 15, 2026 | 140.97M |
| September 14, 2026 | 139.00M |
| September 11, 2026 | 139.98M |
| September 10, 2026 | 137.52M |
| September 09, 2026 | 139.98M |
| September 08, 2026 | 148.36M |
| September 04, 2026 | 147.87M |
| September 03, 2026 | 145.41M |
| September 02, 2026 | 143.93M |
| September 01, 2026 | 142.94M |
| August 31, 2026 | 145.41M |
| August 28, 2026 | 149.35M |
| August 27, 2026 | 151.81M |
| August 26, 2026 | 157.24M |
| August 25, 2026 | 171.04M |
| August 24, 2026 | 168.57M |
| August 21, 2026 | 159.21M |
| August 20, 2026 | 158.71M |
| August 19, 2026 | 153.29M |
| August 18, 2026 | 142.45M |
| August 17, 2026 | 142.94M |
| August 14, 2026 | 142.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 8.911M |
| XTL Biopharmaceuticals Ltd. | 4.778M |
| Kamada Ltd. | 448.28M |
| Can-Fite BioPharma Ltd. | 3.814M |
| Eocene Ltd. | 3.034M |
Market Cap Related Metrics
| PEG Ratio | -0.225 |
| Price to Book Value | 19.81 |
| Price | 2.92 |
| Earnings Yield | -12.04% |
| PEGY Ratio | -0.225 |